Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface

Drug Discovery Today

Volumn 19, Issue 4, 2014, Pages 496-501

  Andrews, David M ^a   Swarbrick, Martin E ^b   Merritt, Andrew T ^c  

^a ASTRAZENECA   (United Kingdom)

^b Cancer Research UK   (United Kingdom)

^c Centre for Therapeutics Discovery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCIAL PHENOMENA; DRUG INDUSTRY; DRUG RESEARCH; FUNDING; ORGANIZATION; PATENT; PROFIT; REVIEW; RISK; SCIENTIST; STRUCTURE ACTIVITY RELATION; TRANSLATIONAL RESEARCH; COOPERATION; DRUG DEVELOPMENT; MEDICAL RESEARCH; MEDICINAL CHEMISTRY; ORGANIZATION AND MANAGEMENT; UNIVERSITY;

BIOMEDICAL RESEARCH; CHEMISTRY, PHARMACEUTICAL; COOPERATIVE BEHAVIOR; DRUG DISCOVERY; DRUG INDUSTRY; RISK; UNIVERSITIES;

EID: 84899562444     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.01.009     Document Type: Review

References (31)

1. S.M. Paul et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
2. C. Ganellin Historical approaches to drug discovery Ars Pharm. 36 1995 329 335
3. J.L. LaMattina The impact of mergers on pharmaceutical R&D Nat. Rev. Drug Discov. 10 2011 559 560
4. W.L. Jorgensen Challenges for academic drug discovery Ang. Chem. Int. Ed. 51 2012 11680 11684
5. D.G. Trist Scientific process, pharmacology and drug discovery Curr. Opin. Pharmacol. 11 2011 528 533
6. A.M. Palmer, and L. Sundstrom Translational medicines research Drug Discov. Today 18 2013 503 505
7. Anon. Harvard Business Review on Aligning Technology With Strategy 2011 Harvard Business Review Press
8. J.B. Vedel et al. Externalizing research through adaptive frameworks Nat. Rev. Drug Discov. 12 2013 723 724
9. R.J. Williams et al. Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective Drug Discov. Today 17 2012 185 187
10. A.L. Hopkins et al. Mission possible Nature 449 2007 166 169
11. R. Wellenreuther et al. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare Drug Discov. Today 17 2012 1242 1248
12. A. Loregian, and G. Pal How academic labs can approach the drug discovery process as a way to synergize with big pharma Trends Microbiol. 21 2013 261 264
13. H. Wild et al. 'Collaborative innovation': regaining the edge in drug discovery Angew. Chem. Int. Ed. 52 2013 2684 2687
14. J. Pisani, and S. Arlington Pharma 2020: Challenging Business Models 2009 PWC
15. V.J. Gurvich, and S.R. Byrn NIPTE: a multi-university partnership supporting academic drug development Drug Discov. Today 18 2013 916 921
16. A.J. Williams Internet-based tools for communication and collaboration in chemistry Drug Discov. Today 13 2008 502 506
17. M. Hohman et al. Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery Drug Discov. Today 14 2009 261 270
18. M. Lee et al. DEGAS: sharing and tracking target compound ideas with external collaborators J. Chem. Inf. Model. 52 2012 278 284
19. T. Sander et al. OSIRIS, an entirely in-house developed drug discovery informatics system J. Chem. Inf. Model. 49 2009 232 246
20. M.D. Brodney et al. Project-focused activity and knowledge tracker: a unified data analysis, collaboration, and workflow tool for medicinal chemistry project teams J. Chem. Inf. Model. 49 2009 2639 2649
21. C.G. Barber et al. 'OnePoint': combining OneNote and SharePoint to facilitate knowledge transfer Drug Discov. Today 14 2009 845 850
22. A. Mayweg et al. ROCK: the Roche medicinal chemistry knowledge application - design, use and impact Drug Discov. Today 16 2011 691 696
23. D.R. Cheshire How well do medicinal chemists learn from experience? Drug Discov. Today 16 2011 817 821
24. G.R. Robb et al. A chemistry wiki to facilitate and enhance compound design in drug discovery Drug Discov. Today 18 2013 141 147
25. D. Talia Workflow systems for science: concepts and tools ISRN Softw. Eng. 2013 1 15
26. A. Bhardwaj et al. Collaborative tools to accelerate neglected disease research: open-source drug discovery model S. Ekins, Collaborative Computational Technologies for Biomedical Research 2011 John Wiley & Sons 321 334
27. S. Ekins et al. Pioneering use of the cloud for development of collaborative drug discovery (CDD) database S. Ekins, Collaborative Computational Technologies for Biomedical Research 2011 John Wiley & Sons 335 361
28. D.A. Norman Viewpoint Commun. ACM 33 1990 4 6
29. M. Papadaki, and G. Hirsch Curing consortium fatigue Sci. Transl. Med. 5 2013 200fs35
30. M.J. Waring et al. Phosphatidylinositol-4-kinase: potent and selective inhibitors of PI4Kα and PI4Kβ Cancer Res. 8 Suppl. 7 2013 2228
31. N.R. Smalheiser et al. Guidelines for negotiating scientific collaboration PLoS Biol. 3 2005 e217